Copertina

Choosing oral antihyperglycaemic drugs in people living with Type 2 diabetes and severe chronic kidney disease

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autore principale:	Mikael Rydén
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Journal of Internal Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Treatment strategies to reduce cardiovascular risk in persons with chronic kidney disease and Type 2 diabetes
di: Faiez Zannad, et al.
Pubblicazione: (2024)

Low‐protein diet for chronic kidney disease: Evidence, controversies, and practical guidelines
di: Denise Mafra, et al.
Pubblicazione: (2025)

Rapid chronic kidney disease progression in younger, First Nations patients in the Northern Territory
di: Winnie Chen, et al.
Pubblicazione: (2025)

Practical recommendations for treating patients with chronic kidney disease in Australia : a multidisciplinary approach
di: M. P. Schlaich, et al.
Pubblicazione: (2026)

Association between famine exposure during infancy and childhood and the risk of chronic kidney disease in adulthood
di: Xiao Liu, et al.
Pubblicazione: (2024)

Lipoprotein(a) concentrations and cardiovascular disease in patients with chronic kidney disease: Results from the German Chronic Kidney Disease study
di: Ida Gruber, et al.
Pubblicazione: (2024)

Subjective and objectives measures of frailty among adults with advanced chronic kidney disease: a cross‐sectional analysis of clinician misclassification
di: Alice Kennard, et al.
Pubblicazione: (2025)

Potassium binders and continuation of renin–angiotensin system inhibitors/mineralocorticoid receptor antagonist in chronic kidney disease and heart failure (the DEMONSTRATE database)
di: Hans Furuland, et al.
Pubblicazione: (2026)

Endoscopic lung volume reduction with endobronchial valves for severe chronic obstructive pulmonary disease: a coming of age in Australia
di: Francis Ratnakumar, et al.
Pubblicazione: (2024)

Caring for Australians and New ZealandeRs with kidney Impairment guideline commentary on kidney disease: improving global outcomes 2025 guidelines for diagnosis and management of autosomal polycystic kidney disease
di: Mia E. Abdy, et al.
Pubblicazione: (2026)

Feasibility and outcomes of kidney transplantation in patients with end‐stage kidney disease after haemopoietic stem cell transplantation
di: Bioh Kim, et al.
Pubblicazione: (2026)

Inter‐organ crosstalk: The kidney's role in systemic health and disease
di: Carmine Zoccali, et al.
Pubblicazione: (2025)

Psychosocial well‐being of adolescents and young adults living with chronic illness
di: Annabel Cavanagh, et al.
Pubblicazione: (2025)

Neurological manifestations of chronic graft versus host disease
di: Tal Koren, et al.
Pubblicazione: (2025)

Current surgical management of chronic thromboembolic pulmonary disease
di: Hayley Barnes, et al.
Pubblicazione: (2024)

Sleep‐disordered breathing and nocturnal hypoxemia in chronic thromboembolic pulmonary disease
di: Hui‐Ting Li, et al.
Pubblicazione: (2024)

Use of sodium–glucose cotransporter‐2 inhibitors among Aboriginal people with type 2 diabetes in remote Northern Territory: 2012 to 2020
di: Matthew J. L. Hare, et al.
Pubblicazione: (2025)

Albuminuria testing rates in people with diabetes, Victoria, 2022–2024: analysis of a pathology dataset
di: Samuel F. McCormick, et al.
Pubblicazione: (2026)

Acute coronary syndrome in patients with autosomal dominant polycystic kidney disease: a systematic review and meta‐analysis
di: Ashraf Ahmed, et al.
Pubblicazione: (2025)

Not just skin deep: reframing chronic inflammatory skin disease as a systemic threat
di: Annika Smith, et al.
Pubblicazione: (2025)

Neurological sequelae of chronic graft‐versus‐host disease: clinical spectrum and management considerations
di: Weihao Cheng
Pubblicazione: (2026)

A challenging case of serum vasoactive intestinal peptide‐negative vasoactive intestinal peptide‐secreting tumour as cause of severe chronic diarrhoea
di: Phillip Te, et al.
Pubblicazione: (2025)

Collagen and microvascular alterations contribute to neuromuscular degeneration and disease progression in chronic intestinal pseudo‐obstruction
di: Elisa Boschetti, et al.
Pubblicazione: (2026)

Evaluation of preventive medicine amongst people living with human immunodeficiency virus attending a hospital‐based care setting
di: Manoshi Perera, et al.
Pubblicazione: (2025)

Secondary prevention of coronary heart disease in Aboriginal and Torres Strait Islander people in primary care
di: Edwina Wing‐Lun, et al.
Pubblicazione: (2025)

Colchicine and the risk of major adverse cardiovascular events in patients with gout and Type 2 diabetes: A nationwide cohort study
di: Minjeong Jeon, et al.
Pubblicazione: (2025)

Metabolomics in cardiometabolic diseases: Key biomarkers and therapeutic implications for insulin resistance and diabetes
di: David Rizo‐Roca, et al.
Pubblicazione: (2025)

Characteristics of Australian and New Zealand patients with chronic lymphocytic leukaemia: a lymphoma and related diseases registry report
di: Arina Martynchyk, et al.
Pubblicazione: (2025)

Proactive inpatient diabetes service model of care observed to decrease severe hyperglycaemia and hypoglycaemia in a ‘real‐world’ Australian hospital setting
di: Karen Van, et al.
Pubblicazione: (2025)

Glucocorticoid‐induced diabetes screening in patients with autoimmune diseases attending hospital outpatient clinics
di: Zhi X. Leang, et al.
Pubblicazione: (2025)

Predictive factors for lower extremity amputations in patients with diabetic foot disease in Central Australia
di: Aadith Ashok, et al.
Pubblicazione: (2025)

Are we disadvantaging smokers by excluding them from kidney transplantation? A single‐centre experience and survey of kidney transplantation units
di: Humam Hazim, et al.
Pubblicazione: (2025)

Diabetes risk reduction diet and risk of liver cancer and chronic liver disease mortality: A prospective cohort study
di: Yun Chen, et al.
Pubblicazione: (2024)

Longitudinal insights into the natural history of Type 2 diabetes among Koreans: A 20‐year community‐based prospective cohort study
di: Wonsuk Choi, et al.
Pubblicazione: (2025)

Safety, tolerability and efficacy of the use of tixagevimab/cilgavimab as pre‐exposure COVID‐19 prophylaxis in kidney and simultaneous pancreas kidney transplant recipients
di: Wai H Lim, et al.
Pubblicazione: (2025)

Service use and glycaemic control of young people with type 1 diabetes transitioning from paediatric to adult care: a 5‐year study
di: Lin Perry, et al.
Pubblicazione: (2024)

Is semaglutide cost‐effective at closing the gap for Aboriginal and Torres Strait Islander Australians with cardiovascular disease and obesity without type 2 diabetes?
di: Satyen Hargovan, et al.
Pubblicazione: (2025)

Tadalafil use is associated with a lower incidence of Type 2 diabetes in men with benign prostatic hyperplasia: A population‐based cohort study
di: Atsushi Takayama, et al.
Pubblicazione: (2024)

Global kidney health: Are we failing the silent pandemic?
di: Taewon Yi, et al.
Pubblicazione: (2026)

Update on chronic pain management
di: Paul Glare, et al.
Pubblicazione: (2025)